Health Canada has recalled eight more blood pressure medications that contain the ingredient valsartan, due to possible impurities linked to an increased risk of cancer. Health Canada announced the expanded recall on Sunday, after testing identified traces of the impurity in products from Teva Canada, one of the top five Canadian pharmaceutical companies in annual sales.
Valsartan is used to treat patients with blood pressure issues, as well as those who have recently suffered a heart attack or heart failure. The affected medication may contain traces of N-nitro-sodi-methyl-amine a “probable human carcinogen” that could increase the risk of cancer through long-term exposure above acceptable levels, Health Canada says.
Anyone who takes valsartan is encouraged to continue doing so, unless instructed otherwise by a health-care provider, Health Canada says. Individuals using a recalled product are urged to get in touch with their doctor to discuss treatment options, as there are still a number of valsartan products not affected by the recall.
For a full list of recalled valsartan medications, visit Health Canada’s website: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67552a-eng.php
Image source: http://www.fox5ny.com/health/